Find answers to your most frequently asked questions about how to participate and data collection below.

If you do not see the answer to your question, please contact us and our staff will be happy to assist you.

What is RICORD?

RICORD is an open database of COVID-19-related medical imaging assembled by RSNA with the help of partners and contributing sites around the world. RICORD can be used by the global radiology research and education communities to gain insights, apply new tools such as artificial intelligence and deep learning, and accelerate clinical recognition of this terrible new disease. Watch RSNA’s RICORD webinar to learn more about this important initiative. 

What types of radiology sites can participate?

Any institution that has the capacity to submit data meeting the minimum data requirements and de-identification protocol can participate. Institutions that can submit imaging studies of COVID-19 negative patients, as well as clinical outcomes and other data correlated to imaging studies are strongly encouraged to do so.

What is the patient population for RICORD?

All patients at least 18 years of age with chest imaging (CT and/or Xray) for suspected COVID-19 infection (for example ICD-10-CM code U07.1 among discharge diagnosis).

Positive infection should be confirmed with one or more of the following:

  • RT-PCR test
  • Positive IgM antibody test
  • Clinical diagnosis using hospital specific criteria

Positive infection encompasses:

  • Patients who are diagnosed prior to hospitalization, but still symptomatic during the hospitalization
  • Patients with a positive test or diagnosis during hospital admission
  • Patients who are symptomatic during the hospitalization and have a confirmed test available only after hospital discharge


  • Patients younger than 18 years of age
  • Patients who did not receive chest imaging (CT and/or Xray)
Does my site need IRB approval to participate?

You should always follow your individual institution’s guidance regarding the necessity of your institutional review board’s (IRB) approval for this initiative. Your hospital IRB will determine whether participation is subject to or exempt from IRB oversight. The U.S. Department of Health & Human Services offers a resource that may help answer your specific IRB questions.

Under what terms will RICORD data be released?

Sites participating in RICORD are required to sign a Data Submission Agreement with identical terms and provisions to the one used by the National Cancer Institute’s Cancer Imaging Archive, which will be the host for the initial public version of RICORD. Sites are also required to deidentify their data in accordance with the specified protocol. Data contributed by many sites will be combined into an organized data resource and made freely available for non-commercial research and educational uses.

When will RICORD launch?

Data submissions began in early June 2020. These submissions are being used in a pilot project to define annotation methods for COVID imaging. Plans are underway to make the first RICORD datasets publicly available in July. Future releases of RICORD will expand the volume and types of data available.

Is there a cost for using RICORD?

The data in RICORD will be freely available for non-commercial research and educational uses.

How long will RICORD acquire data?

We anticipate receiving COVID-19 imaging data through the end of 2020. We will consider extending data submission based on identified needs for additional types or volumes of data to support research.

How do sites participate in RICORD?

Interested sites can complete the expression of interest form. The steps for submitting agreements and selecting, de-identifying and submitting data are outlined on our resources page.

What clinical data is requested to correlate with imaging examinations in RICORD?

RICORD will allow for optional inclusion of key patient clinical characteristics, labs, vitals and outcomes in patients hospitalized with COVID-19. Below is a high-level summary of the types of data captured.




Sex, race/ethnicity, age

Medical history

Cardiac risk factors, COPD,
autoimmune disorders

Admission vital signs

Height, weight, blood pressure, heart rate, oxygen saturation

Laboratory values (admission)

Creatinine, AST, ALT, Troponin, BNP, lymphocyte count, creatinine

Medical therapy (inpatient)

Hydroxychloroquine, lopinavir/ritonavir, Remdesivir

Inpatient interventions

Mechanical ventilation, mechanical
circulatory support

In-hospital outcomes

Mortality, stroke, heart attack,
DVT/PE, discharge

Outpatient outcomes

Mortality, recovery

Can sites contribute COVID imaging data without associated clinical data?

A minimal required set of data elements and laboratory tests is specified in the RICORD data inclusion criteria.

How can researchers access the data in RICORD?

Researchers and educators interested in using the data for non-commercial research and education can get free access by agreeing to the terms of the TCIA Data Use Agreement.